Follow up of echocardiographic parameters
At one week, 15 (52%) patients had FTR improvement. FTR degree was
decreased from moderate to mild in 9 (31%) patients, and decreased from
severe to moderate in 6 (21%) patients (Figure 1). The mean FTR degree
was decreased from 2.4 ± 0.5 to 1.9 ± 0.7, P<0.001. No
patients had FTR deterioration. Meanwhile, RAD decreased from 45.7 ± 5.5
mm to 44.4 ± 5.8 mm (P =0.057), and PASP reduction was observed (44.8 ±
11.8 vs 33.8 ± 8.2, P<0.001). There were no differences in
LVEF and LVEDD between baseline and after LBBAP. During 6 months
follow-up, 13 (45%) patients remained with FTR improvement (Figure 1).
With 9 (31%) patients had mild FTR. The mean FTR degree was decreased
from 2.4 ± 0.5 vs 2.0 ± 0.8, P<0.001. There were no changes in
the pharmacotherapy during follow-up period.